WHI.L

WH Ireland Group Plc
W.H. Ireland Group - Completion of Sale of the Capital Markets Division
15th July 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3077W
W.H. Ireland Group PLC
15 July 2024
 

This announcement contains certain inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

WH Ireland Group Plc

 

("WH Ireland" or the "Company"

and with its subsidiaries the "Group")

Completion of Sale of the Capital Markets Division

Further to the Company's announcement of 3 June 2024, WH Ireland (AIM: WHI) is pleased to confirm that the sale by its wholly owned subsidiary, WH Ireland Limited of the business and certain assets of its Capital Markets Division to Zeus Capital Limited has now completed ("Completion").  

Commenting Phillip Wale, CEO said "This transaction secures an outcome which the Directors believe is beneficial in respect of the overall strategy of the Group".

As stated in the announcement of 3 June 2024, the sale of the Capital Markets Division will help to satisfy the Group's objectives by immediately reducing its liabilities, as well as its working and regulatory capital requirements, while also increasing potential cash inflows if and when the deferred consideration is paid, shortly following the first anniversary of completion of the Transaction.

Information for Nominated Adviser Clients of WH Ireland Capital Markets

With effect from this morning, the majority of WH Ireland's clients have successfully transferred to Zeus Capital Limited. For those clients that have not yet transferred transitional arrangements have been put in place to enable WH Ireland Limited to maintain its Nominated Adviser status for a maximum of a further three months after Completion (i.e. until 14 October 2024). A WH Ireland Qualified Executive will be made available to any remaining clients to continue to perform WH Ireland's Nomad obligations for this period only and to assist them in transferring to Zeus Capital Limited or to a new Nominated Adviser.

Following the disposal of its Capital Markets Division and pursuant to Rule 31 of the AIM Rules for Nominated Advisers, WH Ireland Limited is now prevented from taking on any new Nominated Adviser clients.

For further information please contact:

WH Ireland Group plc        

www.whirelandplc.com

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666



Canaccord Genuity Limited

www.canaccordgenuity.com

Emma Gabriel / Harry Rees               

+44(0) 20 7523 8000



MHP

whireland@mhpgroup.com

Reg Hoare / Charles Hirst  

+44 (0) 7831 406117

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGPUMUMUPCGBP]]>
TwitterFacebookLinkedIn